.png)
November 9, 2026
If you're a runner, hiker, or weekend athlete in Bethesda or McLean nursing a stubborn ache at the back of your heel, you've probably already tried the usual advice: rest, ice, new shoes, maybe a few weeks off the trail. And if the pain keeps coming back the moment you lace back up, you've probably started wondering whether this is something a cortisone shot can fix, something that needs an injection like PRP, or something that's eventually going to land you in an operating room.
That question — PRP or surgery for Achilles tendinopathy — is one of the most common ones we field at DD Podiatry from active adults across the DC metro area, from the C&O Canal towpath regulars in Bethesda to the Capital Crescent and W&OD Trail runners out of McLean. The honest answer is: it depends on how long you've been hurting, how far the tendon has actually degenerated, and what you've already tried. This guide walks through both options in plain terms so you can have an informed conversation with your podiatrist instead of guessing.
Achilles tendinopathy isn't really "tendinitis" in the classic sense of acute inflammation. In most chronic cases — especially the ones that have been nagging for more than six to eight weeks — the tendon fibers themselves have started to break down and disorganize at a microscopic level. Imaging often shows thickening, small areas of degeneration, and sometimes tiny tears within the tendon itself, most commonly a couple of inches above where the tendon meets the heel bone (mid-portion), or right at the insertion.
This distinction matters because it explains why rest alone so often fails. A degenerated tendon doesn't just need a break — it needs a stimulus to actually remodel and rebuild healthier tissue. That's the whole premise behind both eccentric loading programs (like heel-drop exercises) and PRP injections: they're trying to kickstart repair in tissue that's stalled out, not simply calm down inflammation that was never the main problem to begin with.
Platelet-rich plasma (PRP) is created by drawing a small sample of your own blood, spinning it in a centrifuge to concentrate the platelets and growth factors, and injecting that concentrate directly into the degenerated portion of the tendon, usually under ultrasound guidance for accuracy. The idea is to flood the area with the same growth factors your body already uses for tissue repair, at a much higher concentration than it would produce on its own.
Here's where we want to be straightforward with patients, because this is a treatment that gets oversold online: the research on PRP for Achilles tendinopathy is genuinely mixed. Some trials and cohort studies show meaningful improvement in pain and function, particularly for mid-portion tendinopathy that hasn't responded to months of conservative care. Other randomized controlled trials have found PRP performs no better than a placebo saline injection at 6 and 12 months. The most honest summary of the current evidence is that PRP appears to help a meaningful subset of patients — often those earlier in the degenerative process, with good tendon structure left to work with — but it is not a guaranteed fix, and it is not a substitute for a properly loaded rehab program.
What PRP consistently does offer, regardless of where the outcome lands, is a low-risk, low-downtime option. There's no incision, minimal time off your feet, and essentially none of the surgical risks described below. For many of our patients in Bethesda and McLean who are not yet candidates for — or not interested in — surgery, that risk-benefit profile makes PRP a reasonable next step after conservative care has stalled, with clear expectations set up front about the odds of success.
Surgery for Achilles tendinopathy is not a first-line option, and at DD Podiatry we don't recommend jumping to it. It typically becomes the right conversation when a patient has genuinely exhausted conservative measures — months of eccentric loading, activity modification, bracing or orthotic support, and often one or more rounds of PRP or other injection therapy — and is still significantly limited by pain, or when imaging reveals a degree of structural damage (a large partial tear, extensive degeneration, or a significant insertional spur) that isn't going to resolve with regenerative injections alone.
Surgical options range from minimally invasive debridement and tendon scraping to more involved procedures like flexor hallucis longus (FHL) tendon transfer for patients with extensive degeneration, where a portion of a nearby tendon is rerouted to reinforce the weakened Achilles. The right procedure depends entirely on what's found on imaging and during surgical assessment — this is not a one-size-fits-all decision, and it's one we walk through carefully with each patient before recommending a path forward.
For most patients, the recovery timeline is what actually drives the decision — and the contrast between these two options is significant:
Neither option is "better" in the abstract — they're appropriate for different stages of the same problem. The mistake we see most often is patients waiting so long on rest and ice alone that they arrive at a surgical conversation that earlier, more targeted treatment might have avoided, or conversely, patients pursuing injection after injection on a tendon that imaging shows is already too structurally compromised to respond.
Every Achilles evaluation at DD Podiatry starts the same way, whether you're coming to our Bethesda or McLean office: a detailed history of how long you've been dealing with the pain and what's already been tried, a hands-on exam to localize whether this is mid-portion or insertional tendinopathy, and diagnostic ultrasound or MRI when needed to actually see the degree of tendon degeneration rather than guess at it.
That imaging step matters more than most patients expect. Two people with identical symptoms — pain two inches above the heel that flares with running — can have completely different amounts of actual tendon damage, and that difference is exactly what separates a good PRP candidate from someone who needs a surgical conversation now rather than later. We don't recommend a treatment path based on symptoms alone, and we don't recommend surgery until conservative and regenerative options have had a fair, properly structured trial — unless imaging shows damage that makes further delay counterproductive.
Regenerative medicine for tendon conditions is a core focus at DD Podiatry, not an add-on service. Dr. Nam Tran and Dr. Miriam Niktash perform ultrasound-guided PRP injections regularly and are equally comfortable telling a patient honestly when imaging suggests regenerative treatment isn't likely to be enough — a conversation that matters just as much as the injection itself. We also offer shockwave therapy and other regenerative options that may fit between conservative care and surgery depending on what your evaluation shows, so you're never limited to a binary choice.
Both our Bethesda, MD and McLean, VA offices see a steady stream of Achilles tendinopathy cases from the area's running and hiking community, and we take the time to build an imaging-based, individualized plan rather than defaulting to the same protocol for every patient who walks in with heel pain.
If you've been managing Achilles pain for weeks or months and you're not sure whether PRP, continued conservative care, or a surgical evaluation is the right next step, don't keep guessing. Schedule a diagnostic evaluation at our Bethesda or McLean office and we'll walk you through exactly what your imaging shows and what that means for your options.
Call DD Podiatry at (301) 363-2676 to schedule, or request an appointment online. We see patients at both our Bethesda, MD office (6316 Democracy Blvd) and our McLean, VA office (6849 Old Dominion Dr), with same-week appointments typically available.
.png)
.png)
.png)